Perioperative medicine & outcomes

Association between total fluid volume and postoperative morbidity after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

J Clin AnesthPublished Retrospective observational case-control study

Main finding · CCI at day 28 and its association with total day-0 fluid volumeResult — go to the resultOdds ratio 1.12 95% CI 1.06–1.19

Authors' conclusion

In patients undergoing CRS with HIPEC, total fluid balance on the day of surgery-including intraoperative and immediate postoperative fluids-was associated with postoperative morbidity at day 28.

Study context

Population
Patients undergoing CRS with HIPEC, January 2019–June 2024
Participants
132 patients
Comparison
Perioperative fluid volume by Comprehensive Complication Index (CCI) tertile
Outcome
Comprehensive Complication Index (CCI)
Follow-up
Day 28
Methodological detailssingle-centre, multivariable analysis
  • Single-centre
  • Multivariable analysis

Main finding

As reported in the abstract

CCI at day 28 and its association with total day-0 fluid volume

Odds ratio

1.12

95% CI 1.06–1.19

P < 0.001

Perioperative fluid volume by CCI tertile (first vs third)
OR 1.12 (95% CI 1.06–1.19); P < 0.001
Median CCI at day 28 (IQR 0-31)
21

Observational data: associations, not effects.

Secondary outcomes

Intraoperative fluid administration by CCI tertile

P < 0.001

Total day-0 fluid administration by CCI tertile

P < 0.001

Intraoperative fluid use (all patients)

Crystalloids used
132 patients, 100%
Colloids used
16 patients (12%)
Median intraoperative fluid rate, mL/kg/h (IQR 11.0-17.7)
13.6

Safety

At least one postoperative complication

Patients with ≥1 complication
75 (57%)

Original publication

Association between total fluid volume and postoperative morbidity after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Clin Anesth. Published 30 May 2026. doi:10.1016/j.jclinane.2026.112243

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.